Highly sensitive blood test shows promise for early detecti

Most cancers become deadly by keeping a low profile, causing no symptoms until they're too advanced to treat. Ovarian and gastroesophageal cancers are among the most notorious for this sly disease progression, often leading to late-stage diagnoses.

Related Keywords

Dana Farber Cancer Institute , Massachusetts , United States , John Lacava , David Walt , Megan Craig , Brigham Biobank , Martin Taylor , Rockefeller University Laboratory Of Cellular , Department Of Pathology At Massachusetts , Rockefeller University , Structural Biology , Mass General Brigham , Wyss Institute , Biologically Inspired Engineering , Harvard University , Massachusetts General , Mass General Brigham Biobank , Blood , Blood Test , Essay , Biomarker , Biomarker Detection , Dancer , Cancer Biomarker , Fell , Olorectal , Iagnostic , Enetic , Enome , Laboratory , Nanobodies , Prostate , Protein , Eagents , Research ,